Prollenium Medical Technologies Inc.

Prollenium® Medical Technologies Inc. manufactures the Revanesse® range of dermal fillers, SoftFil® micro-cannulas and post-procedure skincare. With FDA, Health Canada and CE approvals, Prollenium® has sold over 5.5 million Revanesse® syringes and 10 million SoftFil micro-cannulas in over 80+ countries worldwide. Prollenium’s two manufacturing facilities in Canada consist of over 80,000 square feet of state of the art R&D & testing laboratories, aseptic clean suites and automated packaging lines. These faclitiies represent the only sites in North America that produce Hyaluronic acid fillers. Through significant investment in R&D and manufacturing, Prollenium® ensures a steady pipeline of innovative medical devices and cosmetics that safely and effectively address the evolving needs of the aesthetic industry.